MoonLake Immunotherapeutics MLTX
NASDAQ MLTX
$11.26 -0.21 (-1.83%)
As of: Oct 2, 2026 · 1:24 PM EDT

MoonLake Immunotherapeutics (MLTX) Return on Assets [ROA] (2021 - 2026)

Updated

MoonLake Immunotherapeutics (MLTX) posted Return on Assets [ROA] of -54.44% for Q2 2026, down 17.56 percentage points from -36.88% a year earlier but up 8.47 percentage points from the prior quarter.

Analysis

MoonLake Immunotherapeutics (MLTX) Return on Assets [ROA] (2021 - 2026) Analysis & Trends

For FY2025, MoonLake Immunotherapeutics' Return on Assets [ROA] came in at -51.05%, down 26.91 percentage points from FY2024.

  • Annual Return on Assets [ROA] shows a four-year change of +33.89 percentage points (FY2021 to FY2025).
  • In prior years, MoonLake Immunotherapeutics' Return on Assets [ROA] was -24.14% in FY2024 (-9.53 pp), -14.61% in FY2023 (+134.49 pp), -149.10% in FY2022 (-64.17 pp) and -84.94% in FY2021.
  • Quarterly Return on Assets [ROA] has run from a low of -85.20% in Q4 2021 to a high of -8.41% in Q1 2024 over five years.
  • On a year-over-year basis, Return on Assets [ROA] has declined in each of the last eight quarters, with an average year-over-year change of -22.90 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q1 2024, with a gain of 76.31 percentage points; the weakest was Q3 2025, with a drop of 33.31 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -62.92% (Q1 2026), -54.92% (Q4 2025) and -48.88% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 MoonLake Immunotherapeutics 995.75 Mn -673.65 Mn - -54.44%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -54.44%
Mar 31, 2026 -62.92%
Dec 31, 2025 -54.92%
Sep 30, 2025 -48.88%
Jun 30, 2025 -36.88%
Mar 31, 2025 -29.89%
Dec 31, 2024 -24.34%
Sep 30, 2024 -15.57%
Jun 30, 2024 -10.50%
Mar 31, 2024 -8.41%
Dec 31, 2023 -8.59%
Sep 30, 2023 -10.46%
Jun 30, 2023 -19.46%
Mar 31, 2023 -84.72%
Dec 31, 2022 -77.98%
Sep 30, 2022 -66.68%
Jun 30, 2022 -32.70%
Mar 31, 2022 -57.43%
Dec 31, 2021 -84.76%
API Access

MoonLake Immunotherapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=MLTX&period=max&api_key=YOUR_API_KEY